{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:59Z","timestamp":1761128579199},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.2515\/therapie:2003067","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T10:17:07Z","timestamp":1174040227000},"page":"415-420","source":"Crossref","is-referenced-by-count":2,"title":["Les grands essais th\u00e9rapeutiques dans l\u2019ost\u00e9oporose"],"prefix":"10.1016","volume":"58","author":[{"given":"Pierre-Jean","family":"Meunier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2003067_bb0580","article-title":"Preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis [draft]","author":"Food and Drug Administration","year":"1994","journal-title":"FDA"},{"key":"10.2515\/therapie:2003067_bb0585","series-title":"Note for guidance on postmenopausal osteoporosis in women","article-title":"Committee for Proprietary Medicinal Products (CPMP)","author":"European Agency for the Evaluation of Medicinal Products (EMEA)","year":"2001"},{"key":"10.2515\/therapie:2003067_bb0590","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.308.6936.1081","article-title":"Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women","volume":"308","author":"Chapuy","year":"1994","journal-title":"BMJ"},{"key":"10.2515\/therapie:2003067_bb0595","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65years of age or older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2003067_bb0600","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-124-4-199602150-00003","article-title":"Vitamin D supplementation and fracture incidence in elderly persons: a randomized placebo-controlled clinical trial","volume":"124","author":"Lips","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.2515\/therapie:2003067_bb0605","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s001980170147","article-title":"A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis","volume":"12","author":"Cranney","year":"2001","journal-title":"Osteoporosis Int"},{"key":"10.2515\/therapie:2003067_bb0610","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"24","key":"10.2515\/therapie:2003067_bb0615","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.2515\/therapie:2003067_bb0620","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis: Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporosis Int"},{"key":"10.2515\/therapie:2003067_bb0625","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial: Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.2515\/therapie:2003067_bb0630","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effects of risedronate on the risk of hip fracture in elderly women: Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2003067_bb0635","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study: PROOF Study Group","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"10.2515\/therapie:2003067_bb0640","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial: Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.2515\/therapie:2003067_bb0645","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2003067_bb0650","first-page":"2060","article-title":"Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis: a 2-year randomized placebo-controlled trial","volume":"87","author":"Meunier","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.2515\/therapie:2003067_bb0655","first-page":"O45","article-title":"Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis [oral presentation]","volume":"13","author":"Meunier","year":"2002","journal-title":"Osteoporos Int"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T02:41:00Z","timestamp":1554259260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059571630124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S004059571630124X"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2003067","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}